These findings suggest that MTE can affect tumor angiogenesis by repressing the expression of angiogenic molecules such as VEGF, VWF, and PDGFRB, a mechanism that counters the HCC development. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.